Filing status
- Accounts due
- 31 January 2028
- Last accounts
- 30 April 2026
- Conf. stmt due
- 9 June 2027
- Last conf. stmt
- 26 May 2026
C.S.T. Pharma Group Holdings Limited
- Incorporated
- 27 June 2018 (8 years)
- Previously known as
- St Topco (UK) Limited (until 6 November 2019)This list may be incomplete. See all names on Companies House
- Industry
- Activities of other holding companies n.e.c. (64209)
- Owned by
- Accounts type
- Group
- Region
- West Midlands
- Address
- Unit 5-7 Tintagel WayAldridgeWalsallWS9 8ER
Charges
- Total
- 4
- Outstanding
- 4
- Part satisfied
- 0
- Satisfied
- 0
Officers 4 active
Officer details are public data from the Companies House register.
Director · Appointed 5 August 2019
British
Born December 1969 (56)
Director · Appointed 28 August 2018
British
Born June 1977 (49)
Director · Appointed 28 August 2018
British
Born May 1964 (62)
Director · Appointed 2 August 2018
British
Born June 1973 (53)
Officer history (2 former)
30 January 2023
1 May 2020
5 August 2019
21 May 2019
28 August 2018
28 August 2018
2 August 2018
27 June 2018
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 27 July 2026
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Company Limited By Shares
Reg. no. 17032933
Former controllers (1)
27 July 2026
Group structure 9 companies
Ownership group derived from the Companies House PSC register
C.S.T. Pharma Group Holdings Limited This company Owns 75–100% of shares
Acer Pharma Limited Owns 75–100% of shares
Arthrous Limited Owns 25–50% of shares
C. S. T. Pharma Limited Owns 75–100% of shares
Curagenix Life Sciences Limited Owns 75–100% of shares
MPT Pharma Limited Owns 75–100% of shares
Fidelis Medical Limited Owns 75–100% of shares
Financials
Figures from 2025 accounts. Newer accounts, made up to 30 April 2026, are filed but not read yet. See them on Companies House
- Profit
- £474,353
- Return on Equity
- 15%
Trend
Shareholder Funds
Balance sheet detail
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Current Assets | £50,333 | ||
| Debtors | £0 | £192,584 | £50,333 |
| Cash | £0 | ||
| Creditors (< 1 year) | £5,625,829 | £2,011,196 | £1,062,103 |
| Net Current Assets | (£5,625,829) | ||
| Shareholder Funds | £3,181,151 | £3,210,013 | £3,136,699 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 5 November 2026 | Group of companies' accounts | 30 April 2026 | ||
| 6 August 2026 | Resolutions | |||
| 28 July 2026 | Notification of a person with significant control | |||
| 28 July 2026 | Cessation of a person with significant control | |||
| 26 May 2026 | Confirmation statement with no updates | 26 May 2026 |
Some other companies at this address
Other companies in this industry
London
Swansea
Carlisle
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →